Sam Altman-backed Retro Biosciences is widening its Alzheimer’s trial after early doses showed no red flags. Most drug trials ...
APLMS will use Singapore, China and India to test how longevity science can translate into function, prevention and healthier ...
Outer Bio’s Yuna platform keeps living human skin functioning for a month, a longer window for testing what actually slows ...
A SIRT6 gene therapy trial in senior beagles hit its primary endpoint, lowering biological age and offering a test bed for human medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results